PATENTS

  • Title: PCT/EP2019/051157. Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions. WO2019141780.

     Inventors:Sonia Fernández-Veledo; Joan Vendrell; Carolina Serena; Victoria Ceperuelo-Mallafré; Enrique Calvo.

     Patent owner: URV, IISPV, CIBERDEM.

     Priority Countries:  Europe.     

     Countries to which it has been extended: USA, Europe, India, Japan, Mexico, China; Australia, Canada.

     Companies exploiting it: SUCCIPRO SL

     Registration date: 2019

  • Title: EP1938254. Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 diabetes mission after bariatric surgery. WO2021001303.

     Inventors:Sonia Fernández-Veledo; Joan Vendrell; Victoria Ceperuelo-Mallafré; Nuria Vilarrasa; Gemma Llauradó.

     Patent owner: URV, IISPV, CIBERDEM.

     Priority Countries:  Europe.     

     Registration date: 2019

  • Title: EP17382615.7. Methods for improving the cell therapy efficacy with mesenchymal stem cell populations. WO2019053295.

     Inventors: Sonia Fernández-Veledo; Joan Vendrell; Carolina Serena; Antonio Zorzano.

     Patent owner: URV, IISPV, CIBERDEM.

     Priority Countries:  Europe.   

     Registration Date: 2017

 

  • Title: Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders.

     Inventors: Mellitus SL (Joan Vendrell Ortega).

     Registratiion Date: 2007

 

  • Title: Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease.

     Inventors: Mellitus SL (Joan Vendrell Ortega).

     Registration Date: 2005

 

  • Title: Use of soluble CD14 for treatment of diseases.

     Inventors: Mellitus SL (Joan Vendrell Ortega).

     Registration Date: 2004